|
Community Clinical Oncology Program
|
5U10CA037422-24
|
$4,282,002
|
$599,480
|
BRUNER, DEBORAH
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Biospecimen Repository
|
2U24CA114734-06
|
$1,040,063
|
$104,006
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
3U10CA021661-35S1
|
$2,923,989
|
$789,477
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
RTOG Tissue Bank
|
3U24CA114734-05S2
|
|
$0
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Radiation Therapy Oncology Group
|
5U10CA021661-35
|
$10,630,221
|
$2,870,160
|
Curran, Walter
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
$8,123
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Neurocognitive Outcomes Following Proton Beam Radiation Therapy for Treatment of
|
1K07CA157923-01
|
$148,426
|
$148,426
|
KAHALLEY, LISA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
$1,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
$58,695
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-03
|
$340,627
|
$340,627
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Infection and Inflammation in Adult Gliomas
|
5K07CA131505-04
|
$135,445
|
$135,445
|
Scheurer, Michael
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
2U10CA035192-27A1
|
$569,700
|
$17,091
|
Nichols, Craig
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
SapC-DOPS nanovesicles for Treating Glioblastoma Multiforme
|
5R44CA136017-03
|
$840,956
|
$840,956
|
Xu, Kevin
|
BEXION PHARMACEUTICALS, INC.
|
|
Combination Therapies for Cancer Treatment
|
5R01CA049248-21
|
$328,240
|
$164,120
|
WAXMAN, DAVID
|
BOSTON UNIVERSITY
|
|
Advanced Training in Surgical Oncology
|
2T32CA009535-24A2
|
$161,835
|
$32,367
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Rapid Analysis of Intraoperatively Acquired DTI for Identification of Key White M
|
1R21CA156943-01A1
|
$333,116
|
$333,116
|
GOLBY, ALEXANDRA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Guided Therapy
|
3P01CA067165-13S1
|
$70,748
|
$31,837
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Guided Therapy
|
5P01CA067165-13
|
$953,612
|
$429,125
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Multidisciplinary Training in Image-Guided Therapy
|
5R25CA089017-09
|
$452,146
|
$90,429
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Validation of microRNA Targets in Glioma
|
5R01CA138734-02
|
$350,894
|
$350,894
|
Krichevsky, Anna
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Image Registration for Ultrasound-Based Neurosurgical Navigation
|
5R01CA138419-03
|
$359,662
|
$359,662
|
WELLS, WILLIAM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Proteo-genomic Discovery, Prioritization and Verification of Cancer Biomarkers
|
1U24CA160034-01
|
$3,034,910
|
$758,728
|
CARR, STEVEN
|
BROAD INSTITUTE, INC.
|
|
Broad Institute Center for Cancer Systems Biology
|
5U54CA112962-07
|
$2,032,718
|
$508,180
|
GOLUB, TODD
|
BROAD INSTITUTE, INC.
|
|
SBIR TOPIC 255 PHASE II: DEVELOPMENT OF ANTICANCER AGENTS
|
N44CO110113-000
|
$1,496,764
|
$299,353
|
BURKHART, CATHERINE
|
BUFFALO BIOLABS, LLC
|
|
Nanosystems Biology Cancer Center 2
|
5U54CA151819-02
|
$2,446,327
|
$611,582
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Sensitizer Delivery for Focused Hyperthermia Cancer Treatment
|
5R01CA136857-03
|
$364,160
|
$182,080
|
Exner, Agata
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S1
|
$73,029
|
$2,921
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-22S2
|
$50,000
|
$2,000
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-22
|
$4,849,180
|
$193,967
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-02
|
$316,002
|
$316,002
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Nanoconjugate based on polymalic acid for brain tumor treatment
|
3U01CA151815-02S1
|
$157,231
|
$157,231
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Nanoconjugate based on polymalic acid for brain tumor treatment
|
5U01CA151815-02
|
$486,001
|
$486,001
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
Epigenetic Regulation of Medulloblastoma
|
4R01CA135454-03
|
$348,876
|
$348,876
|
JACKSON-GRUSBY, LAURIE
|
CHILDREN'S HOSPITAL BOSTON
|
|
Genomic Analysis of Medulloblastomas
|
2R01CA109467-06
|
$748,185
|
$748,185
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
Genetics of pediatric rhabdoid tumors
|
5R01CA046274-20
|
$258,854
|
$85,422
|
BIEGEL, JACLYN
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Regulation of oncogenic signal transduction pathways by inositol polyphosphates
|
5R00CA134914-04
|
$241,530
|
$241,530
|
Resnick, Adam
|
CHILDRENS HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-25
|
$1,147,220
|
$11,472
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumor
|
1R01CA155769-01A1
|
$339,760
|
$339,760
|
BADIE, BEHNAM
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S1
|
$91,911
|
$2,757
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S2
|
$75,000
|
$2,250
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA033572-28S3
|
$139,999
|
$4,200
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA033572-28
|
$2,225,352
|
$66,761
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CpG methylation and mutation
|
5R01CA084469-12
|
$283,061
|
$42,459
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Inhibition of Glioma Growth by a Novel Molecule
|
5R01CA127620-05
|
$289,351
|
$289,351
|
Gladson, Candece
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Brain Endothelial TNF-R1 Can Function to Inhibit Angiogenesis
|
5R01CA152883-02
|
$355,503
|
$355,503
|
Gladson, Candece
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
|
5R01CA151522-02
|
$252,801
|
$252,801
|
Hjelmeland, Anita
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Microenvironmental modulation as a result of glioma therapy
|
1K99CA157948-01A1
|
$98,739
|
$98,739
|
Lathia, Justin
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Integrin regulation of brain tumor initiating cells
|
5F32CA142159-03
|
$51,326
|
$51,326
|
Lathia, Justin
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
|
5R01CA120893-05
|
$284,695
|
$284,695
|
PLAUTZ, GREGORY
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Stem Cell-Like Glioma Cells in Angiogenesis
|
5R01CA129958-04
|
$316,002
|
$316,002
|
RICH, JEREMY
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
Total relevant funding to Brain for this search: $165,109,115
|